|1.||Korsten, Mark A: 4 articles (10/2015 - 01/2004)|
|2.||Spungen, Ann M: 4 articles (10/2015 - 01/2004)|
|3.||Bauman, William A: 4 articles (10/2015 - 01/2004)|
|4.||Nezhinskaia, G I: 4 articles (05/2010 - 07/2005)|
|5.||Sapronov, N S: 4 articles (05/2010 - 07/2005)|
|6.||Roelants, Fabienne: 4 articles (06/2006 - 04/2003)|
|7.||Bharucha, A E: 3 articles (12/2015 - 11/2001)|
|8.||Rosman, Alan S: 3 articles (10/2015 - 07/2005)|
|9.||Radulovic, Miroslav: 3 articles (10/2015 - 01/2004)|
|10.||Sessler, Daniel I: 3 articles (02/2015 - 07/2002)|
01/01/2014 - "Symptoms of myasthenia gravis (measured as improvement in at least one muscle function) improved in nine of the 10 participants after the two-week neostigmine treatment phase. "
03/01/1992 - "The efficacy of intranasally administered neostigmine was tested in 22 patients with generalized myasthenia gravis (MG). "
05/01/1978 - "Since the myopathic changes observed in this study were produced by neostigmine, a drug which is commonly employed in the routine treatment of human patients with myasthenia gravis, continued use of neostigmine for long-term therapy in noncrisis situations may not be accepted as being free from risk."
10/01/2011 - "Cholinergic crisis after neostigmine administration in a dog with acquired focal myasthenia gravis."
03/01/2010 - "A neuromuscular blocking drug (NMBD) induced neuromuscular blockade (NMB) in patients with myasthenia gravis usually dissipates either spontaneously or by administration of neostigmine. "
03/01/1996 - "Neostigmine was more effective for somatic pain than visceral pain. "
06/01/1995 - "However, since pain itself activates bulbospinal inhibitory pathways, neostigmine may be more effective in the postoperative period. "
12/01/2008 - "Injection of 100 microg hyperbaric neostigmine intrathecally was effective for pain relief, and reduced post-operative opiate demand."
10/01/2000 - "Efficacy of intrathecal neostigmine for the relief of postinguinal hemiorrhaphy pain."
01/01/2012 - "The neostigmine model represents a new minimally invasive mouse model to study visceral pain. "
|3.||Colonic Pseudo-Obstruction (Ogilvie Syndrome)
12/01/2012 - "Colonoscopy is superior to neostigmine for Ogilvie's syndrome and should be considered first-line therapy, although neostigmine is useful in select patients and repeat interventions."
12/01/2012 - "Colonoscopy is superior to neostigmine in the treatment of Ogilvie's syndrome."
03/24/2001 - "Neostigmine was recently shown to be effective and safe for the treatment of Ogilvie's syndrome. "
05/01/2000 - "We have shown that neostigmine is a safe and effective treatment for acute colonic pseudo-obstruction."
05/01/2000 - "Neostigmine: safe and effective treatment for acute colonic pseudo-obstruction."
11/01/1980 - "Neostigmine, however, appears to be the most effective in producing an antiblocking action of sufficient magnitude and duration of action to be of value as an antidote in NT poisoning. "
09/01/2011 - "[Neostigmine poisoning caused by mistakenly swallowing in a child]."
02/01/2008 - "We present the case of a patient who presented with a rare myasthenic crisis-like syndrome requiring assisted ventilation due to Cleistanthus collinus poisoning, which responded to treatment with neostigmine."
03/01/1991 - "[The effect of neostigmine on the motor endplate in the intermediate syndrome of organophosphate poisoning]."
11/01/1983 - "[Thiol compounds in the combined therapy of prozerin poisonings]."
01/01/1957 - "[Lack of efficacy of the prostigmine test on myasthenic ocular paralysis]."
01/01/2010 - "The purpose of this study was to investigate the dose-effect relationship of neostigmine to antagonize residual paralysis corresponding to a TOF ratio of 0.4 and 0.6. "
05/01/1988 - "The effect of neostigmine on postoperative intestinal paralysis in 90 patients was investigated in a controlled study. "
08/01/2015 - "Residual paralysis is common at tracheal extubation and PACU arrival, despite qualitative neuromuscular monitoring and the use of neostigmine. "
10/01/2013 - "An experiment using aerosolized neostigmine to reverse paralysis suggests how early interventions could be developed."
|1.||Glycopyrrolate (Glycopyrronium Bromide)
|2.||Clonidine (ST 155)
|3.||Cholinesterase Inhibitors (Anticholinesterases)
|4.||Vecuronium Bromide (Vecuronium)
|9.||Morphine (MS Contin)